H.B. Fuller beats Q2 estimates; raises full-year midpoint outlook
H.B. Fuller Company FUL | 0.00 |
Overview
Adhesives maker's fiscal Q2 net revenue rose 5.8%, beating analyst expectations
Adjusted EPS for fiscal Q2 increased 19% and beat analyst expectations
Company repurchased 750,000 shares and raised midpoint of full-year guidance
Outlook
H.B. Fuller raises midpoint of full-year adjusted EBITDA guidance to $650 mln-$675 mln
Company lifts midpoint of full-year adjusted EPS guidance to $4.60-$4.90
H.B. Fuller expects Q3 adjusted EBITDA of $180 mln-$190 mln
Result Drivers
PRICING EXECUTION - Co said pricing actions increased net revenue and drove margin improvement
RESTRUCTURING SAVINGS - Co said restructuring initiatives contributed to higher gross margin and adjusted EBITDA
FOREIGN CURRENCY - Co said foreign currency translation contributed 3.1% to net revenue growth
Company press release: ID:nBw8Jl01ba
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 Revenue |
Beat |
$950 mln |
$924.79 mln (7 Analysts) |
Q2 Adjusted EPS |
Beat |
$1.41 |
$1.40 (7 Analysts) |
Q2 Adjusted Net Income |
Beat |
$78 mln |
$76.76 mln (6 Analysts) |
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 2 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the specialty chemicals peer group is "buy"
Wall Street's median 12-month price target for H.B. Fuller Company is $72.00, about 14.1% above its June 23 closing price of $63.12
The stock recently traded at 12 times the next 12-month earnings vs. a P/E of 14 three months ago
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
